Reider Paul bought CHRS
January 2, 2024 · Form 4 insider transaction
Reider Paul bought 160,000 shares of Coherus Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
160,000
Price
$0.00
Total value
N/A
InsiderReider Paul
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after160,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.